Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927781 · ClinicalTrials.gov registry record · Phase 3
Perioperative Pregabalin in Ureteroscopy: a Pilot
A Phase 3 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT03927781 is a Phase 3 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 10 participants.
The verdict
NCT03927781, a Phase 3 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators propose a pilot clinical trial on the use of perioperative pregabalin in order to decrease ureteral stent related symptoms and decrease opioid usage after ureteroscopy with stent placement. Patients undergoing ureteroscopy with stent placement will receive a single dose of 300 mg pregabalin PO in the preoperative area. This work will assess safety and feasibility of studying this regimen at our institution, with the aim of performing a randomized, placebo-controlled, double-blinded study in the future.
Interventions
- DRUG Pregabalin 300mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2020-10-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03927781
The ClinicalTrials.gov registry entry for NCT03927781 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pregabalin 300mg is the first listed.
NCT03927781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03927781 about?
NCT03927781 is a clinical study titled "Perioperative Pregabalin in Ureteroscopy: a Pilot". The investigators propose a pilot clinical trial on the use of perioperative pregabalin in order to decrease ureteral stent related symptoms and decrease opioid usage after ureteroscopy with stent placement. Patients undergoing ureteroscopy with stent placement will receive a single dose of 300 mg p...
What is the current status of trial NCT03927781?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2019-04-01. Estimated completion is 2020-10-17.
What interventions are being tested in trial NCT03927781?
The interventions under investigation include: Pregabalin 300mg (DRUG).
Who is sponsoring clinical trial NCT03927781?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.